aOR | 95% CI | P | |
---|---|---|---|
Race | |||
Non-Hispanic White | Reference | ||
Hispanic White | 0.93 | 0.86–1.00 | 0.04 |
Black | 1.19 | 1.12–1.26 | < 0.001 |
Asian/Pacific Islander | 1.03 | 0.95–1.13 | 0.45 |
Age | |||
< 50 years | Reference | ||
50 years or older | 1.05 | 1.00–1.10 | 0.06 |
Facility | |||
Nonacademic | Reference | ||
Academic | 0.98 | 0.94–1.01 | 0.19 |
Insurance | |||
None | Reference | ||
Private | 1.02 | 0.88–1.19 | 0.82 |
Government | 0.97 | 0.84–1.14 | 0.74 |
Income | |||
Above median | Reference | ||
Below median | 1.1 | 1.05–1.16 | < 0.001 |
Education | |||
Above median | Reference | ||
Below median | 1.04 | 0.99–1.08 | 0.12 |
CDS | |||
0 | Reference | ||
1 | 1.02 | 0.97–1.07 | 0.41 |
2 + | 1.09 | 0.99–1.20 | 0.08 |
Year | |||
For every 1 year increase | 0.98 | 0.97–0.99 | < 0.001 |
Histology | |||
Ductal or lobular carcinoma | Reference | ||
Other | 0.74 | 0.70–0.78 | < 0.001 |
PR | |||
Positive | Reference | ||
Negative | 6.59 | 6.31–6.89 | < 0.001 |
T staging | |||
1 | Reference | ||
2 | 1.31 | 1.26–1.36 | < 0.001 |
3 | 0.8 | 0.68–0.92 | 0.003 |
N staging | |||
0 | Reference | ||
1a | 0.8 | 0.76–0.85 | < 0.001 |
Grade | |||
1 | Reference | ||
2 | 2.75 | 2.60–2.91 | < 0.001 |
3 | 16.98 | 16.02–18.02 | < 0.001 |
Other | 21.15 | 13.28–33.64 | < 0.001 |
LVSI | |||
No | Reference | ||
Yes | 1.22 | 1.16–1.28 | < 0.001 |